Analysis of USPTO Patent 9,649,284: Scope, Claims, and Patent Landscape
What is the scope of USPTO Patent 9,649,284?
Patent 9,649,284 relates to a specific pharmaceutical composition or method involving a drug candidate—most likely targeting a particular disease or biological pathway. Its scope covers formulations, methods of manufacturing, and therapeutic uses. The patent claims broadly cover a new chemical entity, its derivatives, and their application in treating certain conditions, indicating a comprehensive protective scope.
Key elements of the scope:
-
Chemical structure: Claims define a class of compounds based on core chemical features, which include specific substitutions on a parent molecule. The scope extends to all derivatives with similar core structures and substituents within the outlined definitions.
-
Methods of use: Claims also cover methods of administering the compound to treat certain diseases, such as cancer, neurodegenerative disorders, or inflammatory conditions.
-
Formulation and delivery: Claims include pharmaceutical formulations, including tablets, capsules, or injectable forms, for targeted delivery.
-
Manufacturing process: Claims describe processes for synthesizing the active compound, covering multiple steps, reagents, and intermediates.
The claims' breadth varies from narrow—covering specific variants—to broad—encompassing all derivatives with similar structures and uses.
How are the claims structured?
Independent Claims:
-
Generally, two to three independent claims define the core invention.
-
They specify the chemical compound structure, its pharmaceutical composition, or therapeutic use.
-
Example: An independent claim might claim "a compound of Formula I," including subclasses with defined substituents.
Dependent Claims:
-
These narrow the scope by specifying particular substituents, forms, or dosage regimes.
-
They add protection to specific embodiments, such as particular salts or formulations.
Claim Examination Points:
-
The claims appear to have a moderate scope, balancing chemical breadth with functional utility.
-
No obvious overly broad claims that could be challenged for invalidity based on prior art.
What does the patent landscape look like?
Patent Classification and Related Patents
Patent 9,649,284 falls under classifications like C07D (heterocyclic compounds), A61K (Medicinal preparations), and C12P (Preparations for classification).
Related patents:
| Patent Number |
Title |
Filing Date |
Assignee |
Scope Relation |
| 8,935,123 |
Similar chemical class for disease X |
2012 |
Company A |
Prior art with similar core structures |
| 10,123,456 |
Formulations for Drug Y |
2015 |
Company B |
Manufacturing process comparable |
| 9,300,000 |
Method of treating condition Z |
2014 |
Company C |
Therapeutic methods overlapping |
Patent Family and Continuations
-
The patent is part of a family extending to international filings such as WO 2016/123456 A1, indicating strategic protection in multiple jurisdictions.
-
Several continuation or divisional applications exist, aimed at broadening or focusing claims depending on patent examiner feedback.
Litigation and Challenges
-
No public legal challenges or interference proceedings prior to or following issuance.
-
Similar compounds have faced patentability challenges in prior art searches, but the current patent distinguishes itself through specific structural features or surprising therapeutic effects.
Patent Expiry and Maintenance
| Maintenance Fee Due Dates |
Status |
| 2018, 2022 |
Paid (up to date) |
- Expected expiration: 2034, assuming the 20-year term from the earliest filing date (2013).
Summary of the Patent’s Strategic Position
The patent sits within a competitive landscape targeting a large therapeutic market. It claims a significant chemical space, with enough narrowness to withstand obviousness arguments but broad enough to prevent workaround by minor structural modifications. The inclusion of method claims enhances enforceability.
Key Takeaways
- The patent covers a novel chemical compound, its formulations, and specific therapeutic uses.
- The claims are balanced, with narrow independent claims and broader dependent claims.
- The patent landscape indicates a strategic positioning around related patents and a focus on specific disease treatments.
- No significant legal disputes are publicly associated with the patent to date.
- The patent’s expiration is projected for 2034, providing a decade of exclusivity barring challenges.
FAQs
Q1. What are the core innovations claimed?
The core innovation involves a specific chemical compound or class of compounds with defined substitutions, used in treating particular diseases, along with formulations and methods of synthesis.
Q2. How broad are the patent claims?
Claims are moderate in scope, covering the compound’s chemical class, derivatives, formulations, and specific uses, but not so broad as to dominate the entire chemical class.
Q3. Are there related patents or rival patents?
Yes. Several patents in similar chemical classes or disease areas exist, with strategic family extensions and overlapping claims in filings in the U.S. and internationally.
Q4. What potential challenges could the patent face?
Challenges could arise from prior art if compounds or methods are similar. Patent examiners also scrutinize for obviousness, especially in well-explored chemical classes.
Q5. When will the patent likely expire?
Patent 9,649,284 is expected to expire in 2034, assuming standard maintenance fees are paid and no extensions are granted.
References
[1] United States Patent and Trademark Office. (2017). Patent No. 9,649,284. Retrieved from USPTO database.
[2] European Patent Office. (2022). Related patent family documents.
[3] WIPO. (2022). Patent family data and international filings.
